106 related articles for article (PubMed ID: 9143247)
1. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy.
Sakai T; Inoue A; Koh CS; Osame M
J Interferon Cytokine Res; 1999 Sep; 19(9):999-1004. PubMed ID: 10505741
[TBL] [Abstract][Full Text] [Related]
3. Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1995 Jan; 56(1):113-6. PubMed ID: 7822477
[TBL] [Abstract][Full Text] [Related]
4. [Detection of the soluble form of the Fas molecule in patients with multiple sclerosis].
Zhou WB; Hans L
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):39-41. PubMed ID: 12212243
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy.
Tsujino A; Nakamura T; Furuya T; Goto H; Nishiura Y; Shirabe S; Nakane S; Motomura M; Nagataki S
J Neurol Sci; 1998 Feb; 155(1):76-9. PubMed ID: 9562326
[TBL] [Abstract][Full Text] [Related]
6. A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases.
Puccioni-Sohler M; Rieckmann P; Kitze B; Lange P; Albrecht M; Felgenhauer K
J Neurol; 1995 Mar; 242(4):239-42. PubMed ID: 7798123
[TBL] [Abstract][Full Text] [Related]
7. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Ohta M; Ohta K; Nishimura M; Saida T
Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
[TBL] [Abstract][Full Text] [Related]
8. The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis.
Puccioni-Sohler M; Kitze B; Felgenhauer K; Graef IT; Lange P; Novis S; Reiber H; Vaz B
Arq Neuropsiquiatr; 1995 Dec; 53(4):760-5. PubMed ID: 8729769
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
J Neuroimmunol; 1994 Jun; 52(1):33-40. PubMed ID: 8207119
[TBL] [Abstract][Full Text] [Related]
10. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.
Ciusani E; Frigerio S; Gelati M; Corsini E; Dufour A; Nespolo A; La Mantia L; Milanese C; Massa G; Salmaggi A
J Neuroimmunol; 1998 Feb; 82(1):5-12. PubMed ID: 9526840
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
Hintzen RQ; Paty D; Oger J
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
[TBL] [Abstract][Full Text] [Related]
12. Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis.
Boylan MT; Crockard AD; McDonnell GV; McMillan SA; Hawkins SA
Immunol Lett; 2001 Oct; 78(3):183-7. PubMed ID: 11578693
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1991 Dec; 35(1-3):285-93. PubMed ID: 1955570
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients.
Saito M; Nakamura N; Nagai M; Shirakawa K; Sato H; Kawahigashi N; Furukawa Y; Usuku K; Nakagawa M; Izumo S; Osame M
J Neuroimmunol; 1999 Aug; 98(2):221-6. PubMed ID: 10430056
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
[TBL] [Abstract][Full Text] [Related]
16. Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
Tsukada N; Miyagi K; Matsuda M; Yanagisawa N
Neurology; 1995 Oct; 45(10):1914-8. PubMed ID: 7477992
[TBL] [Abstract][Full Text] [Related]
17. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.
Fujimoto T; Nakamura T; Furuya T; Nakane S; Shirabe S; Kambara C; Hamasaki S; Yoshimura T; Eguchi K
Intern Med; 1999 Sep; 38(9):717-21. PubMed ID: 10480302
[TBL] [Abstract][Full Text] [Related]
20. Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1.
Sakamoto N; Mukae H; Fujii T; Kakugawa T; Kaida H; Kadota J; Kohno S
Respir Med; 2004 Mar; 98(3):213-9. PubMed ID: 15002756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
